Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Pannecouque

Showing results (181-190 of 428) with videos related to

Pageof 43
Sort By:
Bioorganic & Medicinal Chemistry|June 21, 2011
Synthesis and biological evaluation of novel 5-alkyl-2-arylthio-6-((3,4-dihydroquinolin-1(2H)-yl)methyl)pyrimidin-4(3H)-ones as potent non-nucleoside HIV-1 reverse transcriptase inhibitorsJing Zhang, Peng Zhan, Jingde Wu, et al.
Chemical & Pharmaceutical Bulletin|March 2, 2006
Synthesis and anti-HIV-1 and anti-HCMV activity of 1-substituted 3-(3,5-dimethylbenzyl)uracil derivativesTokumi Maruyama, Shigetada Kozai, Yosuke Demizu, et al.
Bioorganic & Medicinal Chemistry|March 24, 2010
Synthesis and biological evaluation of 4-(hydroxyimino)arylmethyl diarylpyrimidine analogues as potential non-nucleoside reverse transcriptase inhibitors against HIVXiao-Qing Feng, Zhao-Sen Zeng, Yong-Hong Liang, et al.
ACS Infectious Diseases|August 7, 2025
Structure-Based Drug Design Yields Diarylpyrimidine Derivatives as Potent HIV-1 Non-Nucleoside Reverse Transcriptase InhibitorsZhenzhen Zhou, Jie Guo, Xin Li, et al.
The Journal of Antimicrobial Chemotherapy|September 10, 2005
Cell-dependent interference of a series of new 6-aminoquinolone derivatives with viral (HIV/CMV) transactivationMiguel Stevens, Jan Balzarini, Oriana Tabarrini, et al.
Journal of Medicinal Chemistry|December 5, 2009
A 1,8-naphthyridone derivative targets the HIV-1 Tat-mediated transcription and potently inhibits the HIV-1 replicationSerena Massari, Dirk Daelemans, Maria Letizia Barreca, et al.
Journal of Medicinal Chemistry|April 4, 2003
N-aminoimidazole derivatives inhibiting retroviral replication via a yet unidentified mode of actionIrene M Lagoja, Christophe Pannecouque, Arthur Van Aerschot, et al.
Antiviral Chemistry & Chemotherapy|February 19, 2004
Potent and selective inhibition of HIV and SIV by prostratin interacting with viral entryMyriam Witvrouw, Christophe Pannecouque, Valery Fikkert, et al.
European Journal of Medicinal Chemistry|August 30, 2011
Arylazolylthioacetanilide. Part 8: Design, synthesis and biological evaluation of novel 2-(2-(2,4-dichlorophenyl)-2H-1,2,4-triazol-3-ylthio)-N-arylacetamides as potent HIV-1 inhibitorsPeng Zhan, Xuwang Chen, Xiao Li, et al.
Chemical Biology & Drug Design|February 26, 2016
Arylazolyl(azinyl)thioacetanilides: Part 19: Discovery of Novel Substituted Imidazo[4,5-b]pyridin-2-ylthioacetanilides as Potent HIV NNRTIs Via a Structure-based Bioisosterism ApproachXiao Li, Boshi Huang, Zhongxia Zhou, et al.
Pageof 43

Showing results (181-190 of 428) with videos related to

Sort By:
Pageof 43
Bioorganic & Medicinal Chemistry|June 21, 2011
Synthesis and biological evaluation of novel 5-alkyl-2-arylthio-6-((3,4-dihydroquinolin-1(2H)-yl)methyl)pyrimidin-4(3H)-ones as potent non-nucleoside HIV-1 reverse transcriptase inhibitorsJing Zhang, Peng Zhan, Jingde Wu, et al.
Chemical & Pharmaceutical Bulletin|March 2, 2006
Synthesis and anti-HIV-1 and anti-HCMV activity of 1-substituted 3-(3,5-dimethylbenzyl)uracil derivativesTokumi Maruyama, Shigetada Kozai, Yosuke Demizu, et al.
Bioorganic & Medicinal Chemistry|March 24, 2010
Synthesis and biological evaluation of 4-(hydroxyimino)arylmethyl diarylpyrimidine analogues as potential non-nucleoside reverse transcriptase inhibitors against HIVXiao-Qing Feng, Zhao-Sen Zeng, Yong-Hong Liang, et al.
ACS Infectious Diseases|August 7, 2025
Structure-Based Drug Design Yields Diarylpyrimidine Derivatives as Potent HIV-1 Non-Nucleoside Reverse Transcriptase InhibitorsZhenzhen Zhou, Jie Guo, Xin Li, et al.
The Journal of Antimicrobial Chemotherapy|September 10, 2005
Cell-dependent interference of a series of new 6-aminoquinolone derivatives with viral (HIV/CMV) transactivationMiguel Stevens, Jan Balzarini, Oriana Tabarrini, et al.
Journal of Medicinal Chemistry|December 5, 2009
A 1,8-naphthyridone derivative targets the HIV-1 Tat-mediated transcription and potently inhibits the HIV-1 replicationSerena Massari, Dirk Daelemans, Maria Letizia Barreca, et al.
Journal of Medicinal Chemistry|April 4, 2003
N-aminoimidazole derivatives inhibiting retroviral replication via a yet unidentified mode of actionIrene M Lagoja, Christophe Pannecouque, Arthur Van Aerschot, et al.
Antiviral Chemistry & Chemotherapy|February 19, 2004
Potent and selective inhibition of HIV and SIV by prostratin interacting with viral entryMyriam Witvrouw, Christophe Pannecouque, Valery Fikkert, et al.
European Journal of Medicinal Chemistry|August 30, 2011
Arylazolylthioacetanilide. Part 8: Design, synthesis and biological evaluation of novel 2-(2-(2,4-dichlorophenyl)-2H-1,2,4-triazol-3-ylthio)-N-arylacetamides as potent HIV-1 inhibitorsPeng Zhan, Xuwang Chen, Xiao Li, et al.
Chemical Biology & Drug Design|February 26, 2016
Arylazolyl(azinyl)thioacetanilides: Part 19: Discovery of Novel Substituted Imidazo[4,5-b]pyridin-2-ylthioacetanilides as Potent HIV NNRTIs Via a Structure-based Bioisosterism ApproachXiao Li, Boshi Huang, Zhongxia Zhou, et al.
Pageof 43